CAS 2109805-56-1

4-(2-Methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl)-N-(6-(pyridin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide

CAS : 2109805-56-1

Formule : C₂₈H₃₀N₆O₂

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 482.5768

Ref: IN-DA01V3MD

CLK-IN-T3

CAS : 2109805-56-1

CLK-IN-T3

Degré de pureté : ≥98%

Masse moléculaire : 482.58g/mol

Ref: 54-BUP04185

CLK-IN-T3

CAS : 2109805-56-1

CLK-IN-T3 is a small molecule that has been shown to induce apoptosis in cancer cells. CLK-IN-T3 induces the activation of caspase 3, which is involved in the execution phase of apoptosis. CLK-IN-T3 also synergizes with other chemotherapeutic agents, such as doxorubicin and vincristine, to induce cell death. CLK-IN-T3 has been shown to inhibit neurodevelopmental processes and enhances apoptotic signaling pathways in hCT116 colon cancer cells. This drug may be useful for combination strategies for cancer therapy.

Formule : C₂₈H₃₀N₆O₂

Degré de pureté : Min. 95%

Masse moléculaire : 482.6 g/mol

Ref: 3D-JJD80556

CLK-IN-T3

CAS : 2109805-56-1

CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity.

Formule : C₂₈H₃₀N₆O₂

Degré de pureté : 99.61%

Couleur et forme : Solid

Masse moléculaire : 482.58

Ref: TM-T14980